デフォルト表紙
市場調査レポート
商品コード
1458165

デジタルPCRの世界市場規模、シェア、成長分析:技術別、製品タイプ別、用途別 - 産業予測(2024~2031年)

Global Digital PCR Market Size, Share, Growth Analysis, By Technology(droplet digital PCR and chip-based digital PCR ), By Product Type, By Application - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
デジタルPCRの世界市場規模、シェア、成長分析:技術別、製品タイプ別、用途別 - 産業予測(2024~2031年)
出版日: 2024年03月25日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のデジタルPCRの市場規模は、2022年に59億5,000万米ドルとなり、予測期間(2024~2031年)のCAGRは9.14%で、2023年の64億9,000万米ドルから、2031年までに130億7,000万米ドルに成長する見込みです。

世界のデジタルPCR(ポリメラーゼ連鎖反応)市場は、正確な核酸定量と分析に対する需要の高まりにより急成長を遂げています。デジタルPCRは、その比類のない精度と感度で知られ、遺伝子検査、疾病診断、および高度な分子診断ソリューションを提供することを目的とした研究活動において重要なツールとして機能しています。主な促進要因は、個別化医療とゲノム研究の進歩に対する需要の急増と並んで、遺伝性疾患と感染症の有病率の上昇です。しかしながら、デジタルPCR装置の高価格やエンドユーザーの限られた認識といった課題が、市場拡大の妨げとなっています。注目すべき動向は、デジタルPCRと次世代シーケンサー技術の統合や、様々なターゲットを同時に検出するためのマルチプレックスデジタルPCRアッセイの開発です。障害にもかかわらず、新興経済国における採用の増加、腫瘍学や感染症診断におけるアプリケーションの拡大、機能を強化した革新的な製品のイントロダクションから、大きな拡大機会が生じています。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模の推定
  • 市場の前提条件と制限

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

デジタルPCRの世界市場:技術別

  • 市場概要
  • ドロップレットデジタルPCR(ddPCR)・チップベースデジタルPCR(cdPCR)

デジタルPCRの世界市場:製品タイプ別

  • 市場概要
  • 機器
  • 試薬・消耗品
  • ソフトウェア・サービス

デジタルPCRの世界市場:用途別

  • 市場概要
  • 臨床診断
  • 研究
  • 科学捜査
  • 環境モニタリング画像

デジタルPCRの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • Thermo Fisher Scientific(US)
  • Bio-Rad Laboratories(US)
  • QIAGEN(Germany)
  • F. Hoffmann-La Roche Ltd(Switzerland)
  • Fluidigm Corporation(US)
  • Merck KGaA(Germany)
  • Agilent Technologies(US)
  • BioMA(C)rieux SA(France)
  • Takara Bio Inc.(Japan)
  • Danaher Corporation(US)
  • JN Medsys(Singapore)
  • RainDance Technologies(US)
  • Formulatrix, Inc.(US)
  • Stilla Technologies(France)
  • Becton, Dickinson and Company(US)
  • Analytik Jena AG(Germany)
  • Douglas Scientific(US)
  • Sysmex Corporation(Japan)
  • GenMark Diagnostics, Inc.(US)
  • Quantabio(US)
目次
Product Code: SQMIG35G2206

Global Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth due to rising demand for precise nucleic acid quantification and analysis. Digital PCR, known for its unmatched accuracy and sensitivity, serves as a vital tool in genetic testing, disease diagnosis, and research endeavors, aiming to provide advanced molecular diagnostic solutions. Key drivers include the escalating prevalence of genetic disorders and infectious diseases, alongside a surge in demand for personalized medicine and genomic research advancements. Nonetheless, challenges such as the high cost of digital PCR instruments and limited end-user awareness hinder market progression. Noteworthy trends involve the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays for simultaneous detection of various targets. Despite obstacles, significant expansion opportunities arise from increased adoption in emerging economies, widening applications in oncology and infectious disease diagnostics, and the introduction of innovative products with enhanced features.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital PCR Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented on the basis of technology, product type, application, and region. By technology, the market is segmented into droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR). By product type, the market is segmented into instruments, reagents and consumables, and software and services. By application, the market is segmented into clinical diagnostics, research, forensics, and environmental monitoring. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

The significant growth of the market for digital polymerase chain reaction (dPCR) is being propelled by remarkable technological advancements. This evolution from traditional PCR techniques enables direct quantification and clonal amplification of nucleic acids, meeting the rising demand for more precise and efficient diagnostic tools. With a surge in research and development efforts, diverse PCR technologies are emerging, presenting substantial advantages and driving further innovation in the field.

Restraints in the Global Digital PCR Market

The widespread uptake of digital PCR technology might encounter obstacles due to the substantial initial expenses linked with acquiring instruments and reagents. Digital PCR platforms demand specialized equipment and consumables, which could pose a financial challenge for research labs or smaller healthcare institutions. Such high expenditures might restrict the availability of digital PCR technology, especially in resource-constrained environments or for researchers facing budgetary limitations.

Market Trends of the Global Digital PCR Market

The integration of digital PCR and NGS technologies offers a comprehensive approach to genomic analysis, as they complement each other effectively. By combining digital PCR's precise quantification with NGS's sequencing capabilities, researchers can acquire both qualitative and quantitative genomic insights. This integrated approach enables the detection of rare genetic variants, validation of NGS findings, and thorough analysis of intricate genomic changes associated with various diseases.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Digital PCR Market by Technology

  • Market Overview
  • droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR)

Global Digital PCR Market by Product Type

  • Market Overview
  • instruments
  • reagents and consumables
  • and software and services

Global Digital PCR Market by Application

  • Market Overview
  • clinical diagnostics
  • research
  • forensics
  • and environmental monitoring Image

Global Digital PCR Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMA(C)rieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JN Medsys (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RainDance Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Formulatrix, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stilla Technologies (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Analytik Jena AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Douglas Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantabio (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments